{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:48:32Z","timestamp":1790938112720,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6490,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1093\/annonc\/mdf080","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:59:57Z","timestamp":1027724397000},"page":"531-538","source":"Crossref","is-referenced-by-count":120,"title":["Relevance of intraocular involvement in the management of primary central nervous system lymphomas"],"prefix":"10.1016","volume":"13","author":[{"given":"A.J.M.","family":"Ferreri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gubkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Calderoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cortelazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chassagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tinguely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Borisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf080_bb0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.40.1.80","article-title":"Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy","volume":"40","author":"Deangelis","year":"1990","journal-title":"Neurology"},{"key":"10.1093\/annonc\/mdf080_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0305-7372(95)90028-4","article-title":"Primary central nervous system lymphoma in immunocompetent patients","volume":"21","author":"Ferreri","year":"1995","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdf080_bb0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10428199609054837","article-title":"A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in five cases","volume":"23","author":"Soussain","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdf080_bb0025","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","article-title":"Intraocular\u2013central nervous system lymphoma: clinical features, diagnosis, and outcomes","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1093\/annonc\/mdf080_bb0030","first-page":"369","article-title":"Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma)","volume":"61","author":"Rockwood","year":"1984","journal-title":"Report of three cases. J Neurosurg"},{"key":"10.1093\/annonc\/mdf080_bb0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1097-0142(19830901)52:5<878::AID-CNCR2820520523>3.0.CO;2-D","article-title":"Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature","volume":"52","author":"Qualman","year":"1983","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/1097-0142(19930801)72:3<843::AID-CNCR2820720333>3.0.CO;2-#","article-title":"The clinical spectrum of ocular lymphoma","volume":"72","author":"Peterson","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ocii.8.4.243.6463","article-title":"Ocular and central nervous system lymphoma: clinical features and diagnosis","volume":"8","author":"Cassoux","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1093\/annonc\/mdf080_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00006982-199703000-00006","article-title":"Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement","volume":"17","author":"Ursea","year":"1997","journal-title":"Retina"},{"key":"10.1093\/annonc\/mdf080_bb0055","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0025-6196(12)61228-2","article-title":"Primary central nervous system lymphoma","volume":"64","author":"O\u2019Neill","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1093\/annonc\/mdf080_bb0060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bjo.72.12.905","article-title":"Intraocular lymphoma: immunological and cytological analysis","volume":"72","author":"Char","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0065","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0161-6420(87)33256-7","article-title":"Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma","volume":"94","author":"Freeman","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1093\/annonc\/mdf080_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7326\/0003-4819-119-11-199312010-00007","article-title":"Primary central nervous system lymphoma","volume":"119","author":"Fine","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdf080_bb0075","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0161-6420(93)31469-7","article-title":"Intraocular lymphoma. Clinical and histopathologic diagnosis","volume":"100","author":"Whitcup","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1093\/annonc\/mdf080_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bjo.73.5.342","article-title":"Ten-year experience with primary ocular \u2018reticulum cell sarcoma\u2019 (large cell non-Hodgkin\u2019s lymphoma)","volume":"73","author":"Siegel","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0085","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/1097-0142(19860401)57:7<1273::AID-CNCR2820570702>3.0.CO;2-C","article-title":"Treatment of intraocular lymphoma with high-dose Ara-C","volume":"57","author":"Baumann","year":"1986","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0090","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19890515)63:10<1918::AID-CNCR2820631008>3.0.CO;2-D","article-title":"Chemotherapy in the management of intraocular lymphoma","volume":"63","author":"Strauchen","year":"1989","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0095","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.1998.16.9.3000","article-title":"Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma","volume":"16","author":"Sandor","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf080_bb0100","doi-asserted-by":"crossref","first-page":"1329.","DOI":"10.1200\/JCO.1999.17.4.1326c","article-title":"Intraocular methotrexate level after high-dose intravenous infusion","volume":"17","author":"Henson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf080_bb0105","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","article-title":"Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma","volume":"19","author":"Soussain","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf080_bb0115","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.1992.01080220117032","article-title":"Intraocular lymphoma. Immunopathologic analysis of vitreous biopsy specimens","volume":"110","author":"Wilson","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0120","first-page":"446","article-title":"Improving the diagnostic yield of vitrectomy for intraocular lymphoma","volume":"118","author":"Whitcup","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1996.14.2.556","article-title":"Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group Protocol 88-06","volume":"14","author":"Schultz","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf080_bb0130","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V86.8.2922.2922","article-title":"The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin\u2019s lymphoma of patients with no known cause of immunosuppression","volume":"86","author":"Blay","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf080_bb0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3171\/jns.1994.81.2.0188","article-title":"Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome","volume":"81","author":"Glass","year":"1994","journal-title":"J Neurosurg"},{"issue":"Abstr","key":"10.1093\/annonc\/mdf080_bb0140","first-page":"14","article-title":"Combination chemotherapy in the treatment of primary central nervous system and intraocular lymphoma","volume":"A306","author":"Stark-Vancs","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdf080_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.83.4.448","article-title":"Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma","volume":"83","author":"de Smet","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0150","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archopht.1997.01100160322009","article-title":"Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma","volume":"115","author":"Fishburne","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1093\/annonc\/mdf080_bb0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.1989.70.2.0190","article-title":"High-dose methotrexate for non-AIDS primary central nervous system lymphoma","volume":"70","author":"Gabbai","year":"1989","journal-title":"J Neurosurg"},{"key":"10.1093\/annonc\/mdf080_bb0160","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/0959-8049(95)00345-2","article-title":"Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy","volume":"31A","author":"Sarazin","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0165","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(19900501)65:9<1907::AID-CNCR2820650906>3.0.CO;2-L","article-title":"Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine\u2013doxorubicin\u2013cyclophosphamide\u2013prednisolone chemotherapy","volume":"65","author":"Shibamoto","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf080_bb0170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000055310","article-title":"Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients","volume":"60","author":"Ferreri","year":"2001","journal-title":"Oncology"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419618764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419618764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/4\/531\/560752\/mdf080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T07:25:18Z","timestamp":1582183518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419618764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0923753419618764"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf080","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}